Antibiotic combination therapy for ulcerative colitis

Antibiotic combination therapy for ulcerative colitis - Antibiotic combination therapy for ulcerative colitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017844

Enrollment

Registered

2015-06-22

Start date

2015-06-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

amoxicillin, tetracycline, and metronidazole

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: active UC patients

Exclusion criteria

Exclusion criteria: pregnancy history of drug allergy

Design outcomes

Primary

Measure	Time frame
clinical remission in 3 months	—

Countries

Japan

Contacts

Public ContactShigeki Bamba

Shiga University of Medical Science Division of Gastroenterology

sb@belle.shiga-med.ac.jp0775482217

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026